Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Bilia AB in connection with the acquisition of Upplands Motor Stockholm AB, a distributor of Mercedes vehicles
Mandate

Vinge has advised Bilia AB in connection with the acquisition of Upplands Motor Stockholm AB, a distributor of Mercedes vehicles

July 02, 2021 Employment and Benefits Real Estate and Construction M&A Intellectual Property EU, Competition and Regulatory

Vinge has advised Bilia AB (publ) ("Bilia") in connection with the acquisition of Upplands Motor Stockholm AB. The acquired company reported a turnover of approximately SEK 1.2 billion and an operating profit of approximately SEK 48 million for 2020. The acquisition was subject to approval from the Swedish Competition Authority.

Upplands Motor Stockholm AB is an authorized distributor for Mercedes that conducts sales and service operations for Mercedes passenger cars, vans and trucks at four facilities in the Stockholm area. Bilia took possession of the acquired company on 1 July 2021. Upplands Motor Stockholm AB has approximately 250 employees.

Vinge's team primarily consisted of Christian Riddarbo, Linus Adolfsson (M&A), Edin Agic (company law), Hampus Olsson (real estate law), Björn Nicolai (EU and competition law), Anna Backman (employment law and EU and competition law) and Alexander Lindeberg (intellectual property law). Magnus Pauli was the responsible partner.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025